Otsuka Holdings Co., Ltd.
4578 | T
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- Japan
- Address:
- 千代田区神田司町２−９
- Website:
- https://www.otsuka.co.jp/en/
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
Otsuka Holdings Co., Ltd. is a leading Japanese healthcare company committed to improving global health through its two core business segments: pharmaceuticals and nutraceuticals. Otsuka Pharmaceutical develops innovative pharmaceutical solutions for diagnosing and treating various diseases, while its nutraceutical branch offers nutritional products and cosmedics that enhance daily health and wellness. The company is recognized for its unique approach to product development and dedication to holistic health, striving to create impactful healthcare solutions. Otsuka also emphasizes corporate social responsibility, focusing on sustainability and community engagement while expanding its global footprint, as seen with products like POCARI SWEAT. Through continuous innovation, Otsuka Holdings aims to advance healthcare for all.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-05-22 03:58 |
Regulatory News Service
発行登録追補書類（株券､社債券等）
|
Japanese | 101.5 KB | |
| 2025-05-12 06:10 |
Transaction in Own Shares
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
|
Japanese | 26.1 KB | |
| 2025-05-08 09:07 |
Prospectus
発行登録書（株券､社債券等）
|
Japanese | 26.0 KB | |
| 2025-05-07 09:48 |
Inside Information Statement
臨時報告書
|
Japanese | 21.0 KB | |
| 2025-05-02 09:29 |
Regulatory News Service
訂正臨時報告書
|
Japanese | 29.3 KB | |
| 2025-04-14 09:03 |
Transaction in Own Shares
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
|
Japanese | 22.6 KB | |
| 2025-04-01 09:00 |
Inside Information Statement
臨時報告書
|
Japanese | 25.5 KB | |
| 2025-04-01 09:00 |
Inside Information Statement
臨時報告書
|
Japanese | 41.6 KB | |
| 2025-03-31 04:06 |
Regulatory News Service
確認書
|
Japanese | 8.3 KB | |
| 2025-03-31 04:05 |
Internal Control over Financial Reporting
内部統制報告書－第17期(2024/01/01－2024/12/31)
|
Japanese | 23.9 KB | |
| 2025-03-31 04:04 |
Annual Report
有価証券報告書－第17期(2024/01/01－2024/12/31)
|
Japanese | 3.3 MB | |
| 2025-03-21 08:16 |
Inside Information Statement
臨時報告書
|
Japanese | 20.7 KB | |
| 2025-03-14 08:09 |
Regulatory News Service
訂正臨時報告書
|
Japanese | 26.2 KB | |
| 2025-01-10 08:07 |
Transaction in Own Shares
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
|
Japanese | 24.2 KB | |
| 2024-12-13 08:10 |
Transaction in Own Shares
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
|
Japanese | 24.0 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
ABIVAX | France | ABVX | |
|
Addex Therapeutics Ltd | Switzerland | ADXN | |
|
AegirBio AB | Sweden | AEGIR | |
|
AGRONOMICS LIMITED | Isle of Man | ANIC | |
|
AIREA PLC | United Kingdom | AIEA | |
|
Alkaloid AD | North Macedonia | ALK | |
| Alma Yesodot Ltd. | Israel | KVSR | ||
|
Amphastar Pharmaceuticals Inc. | United States of America | AMPH | |
| Ananda Pharma Plc | United Kingdom | N/A | ||
|
AnGes, Inc. | Japan | 4563 |